Wikisage, the free encyclopedia of the second generation, is digital heritage
Topiramate: Difference between revisions
Jump to navigation
Jump to search
m (Under_construction_icon.png) |
m (wlink) |
||
| Line 1: | Line 1: | ||
topiramate compared to phenobarbital result better effect on, both partial, generalized <ref>Comparison of impact on seizure frequency and epileptiform discharges of children with epilepsy from topiramate and phenobarbital</ref> | topiramate compared to phenobarbital result better effect on, both partial, generalized <ref>[http://www.europeanreview.org/wp/wp-content/uploads/993-997.pdf Comparison of impact on seizure frequency and epileptiform discharges of children with epilepsy from topiramate and phenobarbital]</ref> | ||
Qudexy<sup>TM</sup> is an extended release form of topiramate and could be use in patient unable to swalow intact capsules <ref>http://www.epilepsybehavior.com/article/S1525-5050(16)00057-3/abstract</ref> | Qudexy<sup>TM</sup> is an extended release form of topiramate and could be use in patient unable to swalow intact capsules <ref>http://www.epilepsybehavior.com/article/S1525-5050(16)00057-3/abstract</ref> | ||
<gallery>File:Under_construction_icon.png</gallery> | <gallery>File:Under_construction_icon.png</gallery> | ||
Revision as of 03:57, 21 April 2016
topiramate compared to phenobarbital result better effect on, both partial, generalized [1] QudexyTM is an extended release form of topiramate and could be use in patient unable to swalow intact capsules [2]
Links
Topiramate-induced periodic limb movement disorders in a patient affected by focal epilepsy